The Series D round was led by an unnamed multinational that can eventually buy Vivasure upon reaching ‘certain milestones’. Vivasure, a medical device company based in Galway, has just raised €22m to help fund clinical development of its percutaneous vessel closure technology in the EU and US. The company has built a device called PerQseal which it pitches as the first sutureless and fully absorbable synthetic implant for large-bore arterial vessel punctures, available to physicians across Europe for use in transcatheter endovascular procedures.